Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | ANPEP | P15144 | 6/20 | 0.43 |
| ▸ | LAP3 | P28838 | 5/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.34 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17662348 | 1.00 | SLC7A5 (0.44) | SLC7A5ANPEPLAP3ERAP1SLC1A3 | |
| SCHEMBL26498423 | 0.85 | CYP19A1 (0.40) | SLC7A5ANPEPLAP3ERAP1SLC1A3 | |
| SCHEMBL21985604 | 0.83 | SLC1A3 (0.31) | SLC7A5LAP3SLC1A3SLC1A2TSHR | |
| SCHEMBL19361332 | 0.82 | SLC7A5 (0.41) | SLC7A5ANPEPLAP3ERAP1SLC1A3 | |
| SCHEMBL15574890 | 0.81 | MAPT (0.41) | LAP3SLC1A3SLC1A2TSHRALDH1A1 | |
| SCHEMBL14887474 | 0.81 | MAPT (0.41) | LAP3SLC1A3SLC1A2TSHRALDH1A1 | |
| SCHEMBL14989440 | 0.81 | MAPT (0.41) | LAP3SLC1A3SLC1A2TSHRALDH1A1 | |
| SCHEMBL14887353 | 0.81 | MAPT (0.41) | LAP3SLC1A3SLC1A2TSHRALDH1A1 | |
| SCHEMBL14989441 | 0.81 | MAPT (0.41) | LAP3SLC1A3SLC1A2TSHRALDH1A1 | |
| SCHEMBL18274692 | 0.81 | ALDH1A1 (0.35) | SLC7A5TSHRALDH1A1CACNA2D1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210220477-A1 | SITE SPECIFIC ANTIBODY-DRUG CONJUGATES WITH PEPTIDE-CONTAINING LINKERS | MERSANA THERAPEUTICS, INC. | 2021-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210220477-A1 | SITE SPECIFIC ANTIBODY-DRUG CONJUGATES WITH PEPTIDE-CONTAINING LINKERS | CD2BP2, DNPEP, LNPEP | SLC7A5 1253/4885ANPEP 20/4885LAP3 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.